Mathematical modeling of liver enzyme elevation in HIV mono-infection

Mathematical Biosciences

Volumn 242, Issue 1, 2013, Pages 77-85

  Nampala, Hasifa ^a   Luboobi, Livingstone S ^a   Mugisha, Joseph Y T ^a   Obua, Celestino ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

ALT elevation; Hepatocytes; HIV; ODE system

Indexed keywords

ALANINE AMINOTRANSFERASE; ALT ELEVATION; ANTIRETROVIRALS; BASIC REPRODUCTIVE NUMBER; CHEMOKINE RECEPTORS; CO-INFECTIONS; CYTOTOXIC; ENDEMIC EQUILIBRIUM; HEPATOCYTES; HIV; HIV INFECTION; HUMAN HEPATOCYTES; LIVER DAMAGE; LIVER DISEASE; ODE SYSTEM; T-LYMPHOCYTES; TRANSCRITICAL BIFURCATION; VIRAL LOAD;

AMINO ACIDS; ENZYMES; MATHEMATICAL MODELS;

DISEASES;

ALANINE AMINOTRANSFERASE;

DISEASE INCIDENCE; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIVITY; MATHEMATICAL ANALYSIS; NUMERICAL MODEL;

ARTICLE; CALCULATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; FEASIBILITY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRANSAMINASEMIA; LIVER CELL; LIVER INJURY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MIXED INFECTION; MOLECULAR DYNAMICS; PROCESS MODEL; VIRUS LOAD; VIRUS REPLICATION;

ALANINE TRANSAMINASE; BASIC REPRODUCTION NUMBER; COMPUTER SIMULATION; HIV; HIV INFECTIONS; HUMANS; LIVER; MODELS, BIOLOGICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84873255122     PISSN: 00255564     EISSN: 18793134     Source Type: Journal    
DOI: 10.1016/j.mbs.2012.12.005     Document Type: Article

References (31)

1. Babu C., Suwansrinon K., Bren G., Badley A., Rizza S. HIV induces TRAIL sensitivity in hepatocytes. PLoS ONE 2009, 4(2):4623.
2. Powderly W. Antiretroviral therapy in patients with Hepatitis and HIV: weighing risks and benefits. Clinical Infectious Diseases 2004, 38(2):109.
3. Matthews G., Seaberg E., Dore G., Bowden S., Lewin S., Sasadeusz J., Marks P., Goodman Z., Philp F., Tang Y., Stephen L., Thio C. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. NIH Public Access 2009, 23(13):1707.
4. Long C., Qi H., Huang S. Mathematical modeling of cytotoxic lympocyte-mediated immune response to Hepatitis B virus infection. Journal of Biomedicine and Biotechnology 2008, 2008:1.
5. McKoy J., Bennett C., Scheetz M., Differding V., Chandler K., Scarsi K., Yarnold P., Sutton S., Palella F., Johnson S., Obadina E., Raisch D., Parada J. Hepatotoxicity associated with long-versus short-course HIV prophylactic nevirapine use: a systematic review and meta-analysis from the research on adverse drug events and reports (RADAR) project. Journal of Viral Hepatitis 2009, 32(2):147.
6. Gisolf E., Dreezen C., Danner S., Weel J., Weverling G. Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Clinical Infectious Diseases 2000, 31:1234.
7. Iser D., Lewin S. The pathonogenisis of liver disease in the setting of HIV-hepatitis B virus coinfection. Antiviral Therapy 2009, 14:155.
8. Jain M., Opio C., Osuagwu C., Pillai R., Keiser P., Lee W. Do HIV care providers appropriately manage Hepatitis B in coinfected patients treated with antiretroviral therapy?. Clinical Infectious Diseases 2007, 44:996.
9. M. Landrum, A. Fieberg, H. Chun, N. Crum-Cianflone, V. Marconi, A. Weintrob, A. Ganesan, R. Barthel, G. Wortmann, B. Agan, The effect of human immunodeficiency virus on Hepatitis B virus serologic status in co-infected adults, PLoS ONE 5 (1) (2010).
10. Otto S., Day T. A Biologist's Guide to Mathematical Modeling in Ecology and Evolution 2007, Princeton University Press.
11. S. Bajaria, D. Kirschner, CTL action during HIV-1 is determined via interactions with multiple cell types, in: W. Y. Tan and H. Wu (Eds), Deterministic and Stochastic Models of AIDS Epidemics and HIV Infections with Interventions, World Scientific Publishing Co. Pte. Ltd, Singapore, (2005) 219.
12. Vlahakis S., Villasis-Keever A., Gomez T., Bren G., Paya C. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. The Journal of Infectious Diseases 2003, 188:1455.
13. Svegliati-Baroni G., de Minicis S. HIV protein gp120 and chemokines receptor for liver fibrosis. Gut 2010, 59(4):428.
14. Blackard J., Sherman K. HCV/HIV co-infection: time to re-evaluate the role of HIV in the liver?. Journal of Viral Hepatitis 2008, 15:323.
15. Xiao P., Usamia O., Suzuki Y., Ling H., Shimizu N., Hoshino H., Zhuang M., Ashino Y., Gu H., Hattori T. Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4. AIDS 2008, 22:1749.
16. *. The Journal of biological chemistry 2011, 286(4):2665.
17. Crispe I., Mehal W. Strange brew: T cells in the liver. Immunology Today 1996, 17(11):522.
18. Arnaout R., Nowak M., Wodarz D. HIV-1 dynamics revisited: biphasic decay by cytotoxic T-lymphocyte killing?. PLoS ONE 2000, 267:1347.
19. Wodarz D., Nowak M. Immune responses and viral phenotype: do replication rate and cytopathogenicity influence virus load?. Journal of Theorerical Medicine 1999, 2:113.
20. Nowak M., Bangham C. Population dynamics of immune responses to persistent viruses. Science 1996, 272(5258):74.
21. Smith R., Schwartz E. Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be?. Mathematical Biosciences 2008, 212:180.
22. Gumel A., Zhang X.-W., Shivakumar P., Garba M., Shai B. A new mathematical model for assessing therapeutic strategies for HIV infection. Journal of Theoretical Medicine 2002, 4(2):147.
23. Rong L., Gilchrist M., Feng Z., Perelson A. Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility. Journal of Theoretical Biology 2007, 247:804.
24. Perelson A., Kischner D., de Boer R. Dynamics of HIV infections of CD4 T cells. Mathematical Biosciences 1993, 114:81.
25. van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilbria for compartmental models of disease transmission. Mathematical Biosciences 2002, 180:29.
26. Musekwa S., Nyabadza F., Chiyaka C., Das P., Tripathi A., Mukandavire Z. Modelling and analysis of the effects of malnutrition in the spread of cholera. Mathematical and Computer Modelling 2011, 53:1583.
27. Perelson A., Nelson P. Mathematical analysis of HIV-1 dynamics in vivo. Society for Industrial and Applied Mathematics Review 1999, 41(1):3.
28. Weber J. The pathogenesis of HIV-1 infection. British Medical Bulletin 2001, 58:61.
29. Castillo-Chavez C., Song B. Dynamical models of Tuberculosis and their applications. Mathematical Biosciences 2004, 1(2):361.
30. Nowak M., Bonhoeffer S., Shaw G., May R. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. Journal of Theoretical Biology 1996, 184:203.
31. Srivastava P., Chandara P. Modeling the dynamics of HIV and CD4+ T cells during primary infection. Nonlinear Analysis: Real World Applications 2008, 11(2):612.